Medicus Pharma Ltd.
MDCX.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -283.32% | -63.51% | -103.24% | -86.15% | -111.28% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9,404.37% | -38.42% | 57.06% | 43.65% | -109.70% |
| Change in Net Operating Assets | 8.92% | -163.88% | -199.60% | -381.70% | -193.18% |
| Cash from Operations | -86.08% | -110.65% | -156.83% | -148.25% | -849.56% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 129.41% | -13.00% | 934.50% | 934.50% | 373.98% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 299.06% | 21.14% | 121.21% | 47.16% | 7.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 157.57% | 8.18% | 194.60% | 127.59% | 71.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,592.33% | -84.73% | 568.76% | 68.43% | -96.11% |